NCT00954824View on ClinicalTrials.gov

Inflammation and the Metabolic Syndrome in Humans

NACompletedINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

August 31, 2003

Primary Completion Date

November 30, 2007

Study Completion Date

November 30, 2007

Conditions
Metabolic Syndrome X
Interventions
BIOLOGICAL

Endotoxin (LPS)

Single administration low-dose (3 ng/kg) endotoxin (LPS).

Trial Locations (1)

19104

Clinical and Translational Research Center, Hospital of the University of Pennsylvania, Philadelphia

All Listed Sponsors
collaborator

National Heart, Lung, and Blood Institute (NHLBI)

NIH

lead

University of Pennsylvania

OTHER

NCT00954824 - Inflammation and the Metabolic Syndrome in Humans | Biotech Hunter | Biotech Hunter